Insulin therapy as an adjunct to reperfusion after acute coronary ischemia: a proposed direct myocardial cell survival effect independent of metabolic modulation.
about
The impact of glucose-insulin-potassium infusion in acute myocardial infarction on infarct size and left ventricular ejection fraction [ISRCTN56720616]Incretins and selective renal sodium-glucose co-transporter 2 inhibitors in hypertension and coronary heart diseaseInadequate blood glucose control is associated with in-hospital mortality and morbidity in diabetic and nondiabetic patients undergoing cardiac surgery.Single dose GLP-1-Tf ameliorates myocardial ischemia/reperfusion injury.Oleanolic acid: a novel cardioprotective agent that blunts hyperglycemia-induced contractile dysfunction.Salvage of nicotinamide adenine dinucleotide plays a critical role in the bioenergetic recovery of post-hypoxic cardiomyocytes.Possible increase in insulin resistance and concealed glucose-coupled potassium-lowering mechanisms during acute coronary syndrome documented by covariance structure analysis.Mitochondria as a drug target in ischemic heart disease and cardiomyopathyReturn to the fetal gene program: a suggested metabolic link to gene expression in the heart.Cardioprotection and myocardial reperfusion: pitfalls to clinical applicationThe prognostic value of blood glucose level on admission in non-diabetic patients with acute myocardial infarction.Cardioprotective growth factors.Targeting reperfusion injury in acute myocardial infarction: a review of reperfusion injury pharmacotherapy.Contribution of apoptosis in myocardial reperfusion injury and loss of cardioprotection in diabetes mellitus.Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot study.PDE5 Inhibitor Tadalafil and Hydroxychloroquine Cotreatment Provides Synergistic Protection against Type 2 Diabetes and Myocardial Infarction in Mice.Oleuropein Protects Cardiomyocyte against Apoptosis via Activating the Reperfusion Injury Salvage Kinase Pathway In Vitro.Prognostic value of admission blood glucose concentration and diabetes diagnosis on survival after acute myocardial infarction: results from 4702 index cases in routine practice.Insulin promotes T cell recovery in a murine model of autoimmune myocarditis.Cardioprotection by glucose-insulin-potassium: dependence on KATP channel opening and blood glucose concentration before ischemia.Myocardial protection by remote ischaemic pre-conditioning is abolished in sulphonylurea-treated diabetics undergoing coronary revascularisation.Effect of diabetes mellitus and its treatment on ventricular arrhythmias complicating acute myocardial infarction.Effective glycaemic control critically determines insulin cardioprotection against ischaemia/reperfusion injury in anaesthetized dogs.
P2860
Q24813295-CF56A077-B00C-409C-9C9B-C209F62D7563Q26784211-FD6A3755-E968-4F3F-BB52-B27306BFD47EQ33761860-E3FDDE62-7B3E-4270-A6FC-46FCCF1BE91CQ33925948-6DF04B21-D1D3-41C1-90BC-49BF9E1E3785Q34455196-18E79442-3D54-45D0-983C-B1F1B2B4F23BQ36211215-3A10200C-3603-464F-BF05-FF74FFD5093CQ36353539-A346AF02-1445-4301-B206-91D9146346E4Q36426316-7B30F02A-DEAB-4D86-AC62-93A68A0C91D1Q36762995-D119C883-3A83-44FD-98FC-224F91DEBA41Q37298516-478AA526-216E-4917-9696-BA09BB5BA630Q37314571-856FAD4A-68FF-406F-AD4E-2791050580BDQ37393585-FBAB5940-4A52-4889-9FE6-9E051652E7F8Q38010782-8116CAC9-BA7F-4CCE-B513-CCDED8823D60Q38366174-1EA3BE20-B80F-4D31-93F6-49DD1BD934BFQ41741312-9F48B994-A8E4-4257-997F-E5F996F02E32Q41913523-591D670E-D54B-4203-8B92-4039CB362610Q42290403-6969D0CC-B8A3-4033-8DEE-67B998C66DD2Q43262555-E06E3132-3CFE-4E5B-8BAE-165261345D21Q44128710-E8817A51-C9E0-4F40-95AB-468130B7E712Q44814388-7EBD14AD-5897-4F95-8CB1-E81E1245A2A7Q46146090-6F744DA8-5604-4B25-A870-8369617EF8FAQ46447190-141E9BB7-5B37-4656-BE22-AA53EBAE47C4Q54351213-F2D8587A-CFE6-42BC-B329-33CB64647DD1
P2860
Insulin therapy as an adjunct to reperfusion after acute coronary ischemia: a proposed direct myocardial cell survival effect independent of metabolic modulation.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Insulin therapy as an adjunct ...... ndent of metabolic modulation.
@ast
Insulin therapy as an adjunct ...... ndent of metabolic modulation.
@en
type
label
Insulin therapy as an adjunct ...... ndent of metabolic modulation.
@ast
Insulin therapy as an adjunct ...... ndent of metabolic modulation.
@en
prefLabel
Insulin therapy as an adjunct ...... ndent of metabolic modulation.
@ast
Insulin therapy as an adjunct ...... ndent of metabolic modulation.
@en
P1476
Insulin therapy as an adjunct ...... ndent of metabolic modulation.
@en
P2093
Derek M Yellon
Michael N Sack
P304
P356
10.1016/S0735-1097(03)00164-5
P407
P577
2003-04-01T00:00:00Z